Fri, 19 Jun 2026

November 23, 2022

people moves

Hong Kong-based Immuno Cure BioTech names new CFO

FutureCFO Editors November 23, 2022

Immuno Cure BioTech, a clinical stage biotechnology group based in the Hong Kong Science Park specialising in DNA vaccines and immunotherapies,

Recent posts

Cxociety poll: Agility, adaptability for effective finance leadership

Philippines records $611M in foreign direct investments, central bank says

What makes AI pay off

Hong Kong unveils tax-break plan to establish corporate treasury centres

Asia’s private equity firms continue to experiment on AI

AICPA & CIMA unveils platform for finance, accounting profession’s future

Subscribe